Clinical Trials · NCT02325960
A Comparison of Exenatide and Insulin Glargine
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Enrollment
- 44
- Start date
- Jan 2015
- Locations
- 1 site, China
- Primary endpoint
- Mean amplitude of glycemic excursions (MAGE) change from baseline by continuous glucose monitoring system (CGMS)